PLYMOUTH, Minn.--(BUSINESS WIRE)--ev3 Inc. (NASDAQ: EVVV), a global endovascular device company, today reported financial results for its fiscal second quarter of 2007. ev3’s net sales in the second quarter of 2007 increased 29% to $65.4 million versus net sales of $50.6 million in the second quarter of 2006. Second quarter sales growth was broad-based and reflected a strong contribution from each of ev3’s Cardio Peripheral and Neurovascular business segments, as well as a strong contribution from both domestic and international markets.